Sucampo Pharmaceuticals, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Sucampo Pharmaceuticals, Inc.
CIK #0001365216
EDGAR Form CIK 2011 - 2025
10-K [0001365216]
10-Q [0001365216]
3 [0001365216]
4 [0001365216]
5 [0001365216]
8-K [0001365216]
SC 13D [0001365216]
SC 13G [0001365216]
Form 13D/13G Filer Form 13D/13G Subject Filed
LSV Asset Management Sucampo Pharmaceuticals Inc [2018-02-13]
BlackRock Inc Sucampo Pharmaceuticals Inc [2018-02-08]
ING Groep NV Sucampo Pharmaceuticals Inc [2017-12-14]
Linden Capital LP Sucampo Pharmaceuticals Inc [2017-12-08]
BlackRock Inc Sucampo Pharmaceuticals Inc [2017-01-30]
KUNO Sachiko Sucampo Pharmaceuticals Inc [2016-12-29]
Sachiko KUNO Foundation Inc Sucampo Pharmaceuticals Inc [2016-12-29]
UENO Ryuji Sucampo Pharmaceuticals Inc [2016-12-29]
S&R Foundation Sucampo Pharmaceuticals Inc [2016-02-16]
BlackRock Inc Sucampo Pharmaceuticals Inc [2016-01-28]
View All
Form 3/4/5 Subject 2011 - 2025
Sucampo Pharmaceuticals, Inc.
Ueno Ryuji
Kuno Sachiko
Meyenburg Jason Patrick
Bryan Jones W.
Pfreundschuh Peter P
Lichtlen Peter
Edick Paul R
Driggs Alex
Smith Karen L.
Donley Matthew Maxwell
Kiener Peter A
Johnson John
Greenleaf Peter
Oconnell Maureen
Walbert Timothy P
Spiegel Robert J.
Alder Matthias
Smith Andrew P
S&R Technology Holdings, LLC
Getman Daniel P
Miele Stanley G
Knapp Thomas J
Munder Barbara A
Tolliver Kei S
Celeste Anthony C.
Ashton William
Claiborne Cary J
Dolecek Gayle R
Maudlin Timothy I
ORIX Corp
Nantahala Capital Management, LLC
Terms | Privacy | Guide
tony@aum13f.com